@article{10.25259/MEDINDIA_5_2021, title = {Marked asymptomatic hyperuricemia; menace induced by antitubercular therapy – A case report}, author = {Rijal, Prabhat and Raina, Rohit and Pathania, Monika and Kant, Ravi}, abstract = { Antitubercular therapy has revolutionized the treatment of all forms of tuberculosis however it is not devoid of adverse effects. Different drugs within the ATT have their specific as well as common side effects which may lead to non-adherence to the treatment as well as treatment failure. Hyperuricemia is one of the established adverse effects of pyrazinamide, with a little contribution from ethambutol. Pyrazinamide is known to have direct impact transport at the level of proximal convoluted tubule in kidney. In the case report that follows, we will be discussing an unusual case of asymptomatic ATT-induced hyperuricemia. A 28-year middle class female, without no known comorbidities who was started ATT empirically on clinical backgrounds develops profound hyperuricemia in the absence of any symptoms such as joint pain, swelling of joints, and flank pain. }, volume = 1, pages = {2}, journal = {Medicine India}, issn = {2831-7890}, url = {https://doi.org/10.25259/MEDINDIA_5_2021}, doi = {10.25259/MEDINDIA_5_2021} }